home All News open_in_new Full Article

« Après vingt ans d’échecs, le risque de récidive des cancers ORL recule de 24 % »

Bonne nouvelle sur le front du cancer ! Une etude europeenne demontre l'efficacite de l'immunotherapie dans les cancers ORL a haut risque. Entretien avec le D r Yungan Tao.


today 5 d. ago attach_file Science

attach_file Science
attach_file Science
attach_file Science
attach_file Events
attach_file Science
attach_file Science
attach_file Science
attach_file Science
attach_file Science
attach_file Events
attach_file Science
attach_file Science
attach_file Science
attach_file Science
attach_file Science
attach_file Science
attach_file Politics
attach_file Science


ID: 4184034765
Add Watch Country

arrow_drop_down